A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial

BACKGROUND: Up-front surgery followed by postoperative chemotherapy remains the standard paradigm for the treatment of patients with resectable pancreatic cancer. However, the risk for positive surgical margins, the poor recovery after surgery that often impairs postoperative treatment, and the comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Simionato, Francesca, Zecchetto, Camilla, Merz, Valeria, Cavaliere, Alessandro, Casalino, Simona, Gaule, Marina, D’Onofrio, Mirko, Malleo, Giuseppe, Landoni, Luca, Esposito, Alessandro, Marchegiani, Giovanni, Casetti, Luca, Tuveri, Massimiliano, Paiella, Salvatore, Scopelliti, Filippo, Giardino, Alessandro, Frigerio, Isabella, Regi, Paolo, Capelli, Paola, Gobbo, Stefano, Gabbrielli, Armando, Bernardoni, Laura, Fedele, Vita, Rossi, Irene, Piazzola, Cristiana, Giacomazzi, Serena, Pasquato, Martina, Gianfortone, Morena, Milleri, Stefano, Milella, Michele, Butturini, Giovanni, Salvia, Roberto, Bassi, Claudio, Melisi, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745557/
https://www.ncbi.nlm.nih.gov/pubmed/33403007
http://dx.doi.org/10.1177/1758835920947969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745557/
https://www.ncbi.nlm.nih.gov/pubmed/33403007
http://dx.doi.org/10.1177/1758835920947969

Ejemplares similares